Atlas Trials

Coherus Oncology, Inc.

18 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Coherus Oncology, Inc.

RecordFirmDate
A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors (NCT06389526)Coherus Oncology, Inc.2025-02-15
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma (NCT06679985)Coherus Oncology, Inc.2024-12-20
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer (NCT06457503)Coherus Oncology, Inc.2024-11-01
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors (NCT05757492)Coherus Oncology, Inc.2023-04-26
Study of CHS-114 in Participants With Advanced Solid Tumors (NCT05635643)Coherus Oncology, Inc.2022-12-15
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma (NCT05359861)Coherus Oncology, Inc.2022-04-12
Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer (NCT05177770)Coherus Oncology, Inc.2022-01-17
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca (NCT04662892)Coherus Oncology, Inc.2020-08-01
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors (NCT04374877)Coherus Oncology, Inc.2020-04-22
Study of SRF617 in Patients With Advanced Solid Tumors (NCT04336098)Coherus Oncology, Inc.2020-03-16

Track Coherus Oncology, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.